[17] Another explanation is that subjects with high EPC numbers in the high risk NNV-ARMD group may be at higher risk for developing NV-ARMD or other angiogenic events in the future. We provided a survey at six months or the next standard of care follow-up visit but it is conceivable that these subjects are at risk beyond this time period. Finally, although cell surface markers used to detect EPCs (CD34+VEGFR2+CD45–) were similar in both FACS and ARCA, the nuclear markers used to identify mononuclear cells in FACS (7-AAD) and ARCA (DAPI) were different. This evidence concerns the gene CD34 and age-related macular degeneration.